Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury
Menk M; Graw JA; von Haefen C; Steinkraus H; Lachmann B; Spies CD; Schwaiberger D · 2018 · Journal of Inflammation Research
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
Mario Menk, Jan Adriaan Graw, Clarissa von Haefen, Hendrik Steinkraus, Burkhard Lachmann, Claudia D Spies, David Schwaiberger Department of Anesthesiology and Operative Intensive Care Medicine, Charité – University Medicine Berlin, FreieUniversität Berlin, Humboldt-Universitätzu Berlin, and Berlin Institute of Health, Germany Purpose: Although the role of the angiotensin II type 2 (AT2) receptor in acute lung injury is not yet completely understood, a protective role of this receptor subtype has been suggested. We hypothesized that, in a rodent model of acute lung injury
Abstract by Menk M; Graw JA; von Haefen C; Steinkraus H; Lachmann B; Spies CD; Schwaiberger D, Journal of Inflammation Research (2018) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Kinin B 1 receptors contributes to acute pain following minor surgery in humans
Negative / Null Result ReportComparative study of hematological parameters among smokers and nonsmokers in Basra city, Iraq
Negative / Null Result ReportInteraction of chronic daily headache, dietary intake of iron, and FTO genotype
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: DOAJ